BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1138 related articles for article (PubMed ID: 19032359)

  • 21. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
    Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
    Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine induces Th2 activation through the histamine receptor 1 in house dust mite rhinitic but not asthmatic patients.
    Botturi K; Lacoeuille Y; Vervloet D; Magnan A
    Clin Exp Allergy; 2010 May; 40(5):755-62. PubMed ID: 20184607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
    Powell N; Till SJ; Kay AB; Corrigan CJ
    Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization to house-dust mite and mite fauna in selected children's homes in Kütahya, Turkey.
    Akdemir C; Yilmaz S
    Turk J Pediatr; 2009; 51(3):232-7. PubMed ID: 19817266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic mice expressing the T cell antigen receptor specific for an immunodominant epitope of a major allergen of house dust mite develop an asthmatic phenotype on exposure of the airways to allergen.
    Jarman ER; Tan KA; Lamb JR
    Clin Exp Allergy; 2005 Jul; 35(7):960-9. PubMed ID: 16008685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals.
    Turcanu V; Winterbotham M; Kelleher P; Lack G
    Clin Exp Allergy; 2008 Jul; 38(7):1132-9. PubMed ID: 18564333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy.
    Bronnert M; Mancini J; Birnbaum J; Agabriel C; Liabeuf V; Porri F; Cleach I; Fabre A; Deneux I; Grandné V; Grob JJ; Berbis P; Charpin D; Bongrand P; Vitte J
    Clin Exp Allergy; 2012 Sep; 42(9):1406-15). PubMed ID: 22747483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergy to house dust mites in primary health care subjects with chronic or recurrent inflammatory states of respiratory system.
    Paszkowski J; Łopatyński J
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):522-30. PubMed ID: 12898969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggravation of airway inflammation and hyper-responsiveness following nasal challenge with Dermatophagoides pteronyssinus in perennial allergic rhinitis without symptoms of asthma.
    Wang W; Xian M; Xie Y; Zheng J; Li J
    Allergy; 2016 Mar; 71(3):378-86. PubMed ID: 26595454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-cell responses to Trichophyton tonsurans: inhibition using the serum free medium Aim V.
    Slunt JB; Taketomi EA; Platts-Mills TA
    Clin Exp Allergy; 1997 Oct; 27(10):1184-92. PubMed ID: 9383259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validated safety predictions of airway responses to house dust mite in asthma.
    Ravensberg AJ; van Rensen EL; Grootendorst DC; de Kluijver J; Diamant Z; Ricciardolo FL; Sterk PJ
    Clin Exp Allergy; 2007 Jan; 37(1):100-7. PubMed ID: 17210047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man.
    Frew AJ; Kay AB
    J Immunol; 1988 Dec; 141(12):4158-64. PubMed ID: 2974055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
    Korn S; Beier J; Heilmann C; Kornmann O; Buhl R; Michael Beeh K
    Respir Med; 2005 Dec; 99(12):1595-9. PubMed ID: 16291080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.